IREN Ltd (IREN)
NASDAQFinancialsCapital MarketsSnapshot 2026-07-08
$43.01+8.01%
Close 2026-07-08 · 1-day change
Reading IREN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track IREN free→NASDAQFinancialsCapital MarketsSnapshot 2026-07-08
Reading IREN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track IREN free→Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Investment Banking & Brokerage is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
IREN's growth depends on the performance of the Financials sector. If sector leaders like MS, GS, and SCHW continue to beat earnings, IREN could benefit. Revenue growth has been weak recently, and there is no earnings yield to read. IREN trades at a high multiple compared to peers, which suggests it looks expensive. If sector bellwethers start missing earnings, IREN's support could weaken. Peer multiples imply a price about 368% below where it trades; this read is provisional.
Trailing returns as of 2026-07-08. IREN is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 16 analysts currently covering IREN (as of Jul 2026).
Based on 6 Wall Street analysts offering 12-month price targets for IREN in the last 4 months.
A consensus fair price across 6 valuation methods, at three horizons. Current price $43.01. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus peers — fair value, gap to price, and forward P/E.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-08. EPS is implied from price ÷ P/E. Not investment advice.
Current $43.01
The last 12 months of price, then the range of analyst 12-month targets from today’s $43.01.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.